IMEDICOM

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

IMEDICOM - overview

Established

2004

Location

Gunpo, Gyeonggi, South Korea

Primary Industry

Medical Devices & Equipment

About

Established in 2004 and based in South Korea, South Korea is a healthcare company that focuses on research. development, manufacturing and sales of orthopedic, spine, ENT and veterinary products. In 2018, the company was granted patent registration – Catheter and Manufacturing Method Thereof (US 9,901,712 B2) 02 and patent registration – Connector for Catheter (10-1839894). The company self-developed include orthopedic surgical devices such as surgical handpieces, battery/pneumatic devices, saw blades/burrs, electric acetabular cups, removal systems and synthetic bone substitutes, spinal surgical equipment such as balloon Kyphoplasty system/Vertebroplasty system and epidural catheters, and ENT surgical equipment such as Balloon Sinuplasty System h Eustachian tube.


Current Investors

Korea Investment & Securities, AJU IB Investment, ID Ventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors, Therapeutic Devices

Website

www.imedicom.co.kr

Verticals

Manufacturing

Company Stage

Late Stage

Total Amount Raised

Subscriber access only

IMEDICOM - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary Stock PurchaseCompletedIMEDICOM-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.